Health Care & Life Sciences » Pharmaceuticals | Lansen Pharmaceutical Holdings Ltd.

Lansen Pharmaceutical Holdings Ltd. | Income Statement

Fiscal year is January-December. All values HKD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
737,455.00
905,878.70
723,695.00
736,067.20
697,332.40
445,736.90
Cost of Goods Sold (COGS) incl. D&A
336,894.20
426,321.40
356,664.90
323,151.10
297,444.00
213,055.80
Gross Income
400,560.80
479,557.30
367,030.10
412,916.10
399,888.40
232,681
SG&A Expense
303,331.30
355,156.70
300,125.40
342,044.90
339,369.40
242,517.20
EBIT
-
124,400.60
66,904.70
79,107.20
60,519.00
6,230.90
Unusual Expense
2,544.20
5,653.20
63,834.70
13,910.30
39,836.90
18,433.90
Non Operating Income/Expense
19,546.70
24,186.90
30,948.30
574.40
127,872.30
50,332.70
Interest Expense
12,821.70
23,046.90
26,172.70
25,701.50
30,454.30
32,275
Pretax Income
104,644.90
123,392.50
16,815.30
43,252.40
122,736.90
16,380.50
Income Tax
26,295.00
31,701.10
17,520.80
24,762.20
11,034.60
15,126.50
Equity in Affiliates
12,333.10
16,719.10
16,761.10
11,286.60
10,091.70
-
Consolidated Net Income
90,682.90
108,410.50
16,055.60
29,776.80
121,793.90
1,254
Net Income
90,682.90
108,410.50
16,055.60
29,776.80
121,793.90
1,254
Net Income After Extraordinaries
90,682.90
108,410.50
16,055.60
29,776.80
121,793.90
1,254
Net Income Available to Common
90,682.90
108,410.50
16,055.60
29,776.80
121,793.90
1,254
EPS (Basic)
0.22
0.26
0.04
0.07
0.30
-
Basic Shares Outstanding
415,000.00
415,000.00
415,000.00
415,000.00
415,000.00
414,999.50
EPS (Diluted)
0.22
0.26
0.04
0.07
0.29
-
Diluted Shares Outstanding
415,000.00
415,000.00
415,000.00
415,000.00
415,000.00
414,999.50
EBITDA
116,186.70
150,130.70
93,193.70
105,841.10
88,806.90
35,065.20
Other Operating Expense
-
-
-
8,236.00
-
16,067
Non-Operating Interest Income
3,234.50
3,505.10
8,969.70
4,331.50
4,636.70
3,652.30

About Lansen Pharmaceutical Holdings

View Profile
Address
228 Xinfeng Road
Ningbo Zhejiang 315174
China
Employees -
Website http://www.lansen.com.cn
Updated 07/08/2019
Lansen Pharmaceutical Holdings Ltd. engages in the development, manufacture, and distribution of pharmaceuticals products. It operates through the following segments: Pharmaceuticals, Medicinal Cosmetics Products, and Healthcare Products. The Pharmaceuticals segment develops, produces, and sells specialty pharmaceuticals mainly used in the field of rheumatology and dermatology and other pharmaceuticals.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.